+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Surface Markers Market by Product, Source, Cell Type, Application, End-User - Global Forecast 2025-2030- Product Image
Cell Surface Markers Market by Product, Source, Cell Type, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Cell Surface Markers Market by Product, Source, Cell Type, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010769
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Surface Markers Market grew from USD 785.86 million in 2023 to USD 858.27 million in 2024. It is expected to continue growing at a CAGR of 9.30%, reaching USD 1.46 billion by 2030.

Cell surface markers are proteins or antigens present on the surface of cells that can be used to identify and categorize different cell types. The scope of cell surface markers extends primarily to their application in diagnostics, immunology, and targeted therapy, facilitating precision medicine. They are crucial in cellular research, allowing for the differentiation and isolation of cell populations, which is vital in the study of stem cells, cancer, and immune responses. The necessity of cell surface markers arises from their role in diagnosing diseases through flow cytometry and immunohistochemistry, tracking disease progression, and assessing therapeutic efficacy. Their application spans across healthcare and biotechnology sectors, impacting research in cancer, autoimmune diseases, and organ transplantation.

The market growth for cell surface markers is substantially influenced by advancements in precision medicine, increased funding for life sciences research, and a rising prevalence of chronic diseases. The integration of AI and machine learning in biotechnology, along with growing adoption of high-throughput screening methods, present significant opportunities. Companies can capitalize on these trends by investing in AI-driven diagnostic tools and expanding their service offerings in molecular diagnostics. However, market growth faces challenges such as the complex regulatory landscape, high developmental costs, and limited standardization in methodologies, which can affect the pace of innovation.

To mitigate these challenges and drive innovation, investments in R&D focused on developing cost-effective, scalable solutions are recommended. Emphasizing collaborations between biotech firms and academic institutions can facilitate breakthrough discoveries and novel product developments. Additionally, opportunities exist in enhancing the sensitivity and specificity of diagnostic assays, as well as exploring emerging markets where the demand for advanced medical diagnostics is rising. The market exhibits a dynamic nature, characterized by rapid technological advancements and increasing competition. As such, continuous monitoring of technological trends and consumer needs remains crucial to sustaining business growth and competitive advantage in the field of cell surface markers.

Understanding Market Dynamics in the Cell Surface Markers Market

The Cell Surface Markers Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Expanding healthcare, life sciences, and pharmaceutical industries
    • Rising need for adoption of in vitro diagnostics
    • Growing occurrence rate of cancer and other autoimmune diseases
  • Market Restraints
    • High costs associated with cell research activities
  • Market Opportunities
    • Growing investment in research and development to launch new drugs
    • Rising technological advancement in the healthcare sector
  • Market Challenges
    • Complexities associated with instruments and stringent regulatory compliances

Exploring Porter’s Five Forces for the Cell Surface Markers Market

Porter’s Five Forces framework further strengthens the insights of the Cell Surface Markers Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cell Surface Markers Market

External macro-environmental factors deeply influence the performance of the Cell Surface Markers Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cell Surface Markers Market

The Cell Surface Markers Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cell Surface Markers Market

The Cell Surface Markers Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cell Surface Markers Market

The Cell Surface Markers Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Surface Markers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., arigo Biolaboratories Corp., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., Creative Bioarray, Creative Diagnostics, Danaher Corporation, F. Hoffmann-La Roche Ltd., GenScript Biotech Corporation, Grifols SA, Merck KGaA, Nihon Kohden Corporation, PerkinElmer Inc., Qiagen N.V., Qima Ltd., R&D Systems, Inc., ScienCell Research Laboratories, Inc., Siemens Healthineers AG, Stemcell Technologies Inc., Sysmex Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Surface Markers Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Antibodies
    • PCR Arrays
  • Source
    • Mice
    • Rats
  • Cell Type
    • B Cell Surface Markers
    • Monocyte Cell Surface Markers
    • NK Cell Surface Markers
    • T Cell Surface Markers
  • Application
    • Clinical
      • Immunodeficiency Diseases
      • Oncology
    • Research
      • Drug Discovery
      • Immunology
      • Stem Cell Research
  • End-User
    • Academic & Research Institutes
    • Hospitals & Clinical Testing Laboratories
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries
5.1.1.2. Rising need for adoption of in vitro diagnostics
5.1.1.3. Growing occurrence rate of cancer and other autoimmune diseases
5.1.2. Restraints
5.1.2.1. High costs associated with cell research activities
5.1.3. Opportunities
5.1.3.1. Growing investment in research and development to launch new drugs
5.1.3.2. Rising technological advancement in the healthcare sector
5.1.4. Challenges
5.1.4.1. Complexities associated with instruments and stringent regulatory compliances
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cell Surface Markers Market, by Product
6.1. Introduction
6.2. Antibodies
6.3. PCR Arrays
7. Cell Surface Markers Market, by Source
7.1. Introduction
7.2. Mice
7.3. Rats
8. Cell Surface Markers Market, by Cell Type
8.1. Introduction
8.2. B Cell Surface Markers
8.3. Monocyte Cell Surface Markers
8.4. NK Cell Surface Markers
8.5. T Cell Surface Markers
9. Cell Surface Markers Market, by Application
9.1. Introduction
9.2. Clinical
9.2.1. Immunodeficiency Diseases
9.2.2. Oncology
9.3. Research
9.3.1. Drug Discovery
9.3.2. Immunology
9.3.3. Stem Cell Research
10. Cell Surface Markers Market, by End-User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Hospitals & Clinical Testing Laboratories
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Cell Surface Markers Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Cell Surface Markers Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Cell Surface Markers Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CELL SURFACE MARKERS MARKET RESEARCH PROCESS
FIGURE 2. CELL SURFACE MARKERS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELL SURFACE MARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. CELL SURFACE MARKERS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. CELL SURFACE MARKERS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CELL SURFACE MARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELL SURFACE MARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CELL SURFACE MARKERS MARKET DYNAMICS
TABLE 7. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PCR ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY B CELL SURFACE MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCYTE CELL SURFACE MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY NK CELL SURFACE MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY T CELL SURFACE MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. CANADA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. CANADA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56. CANADA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 59. CANADA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 60. CANADA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. CHINA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. CHINA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 93. CHINA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 94. CHINA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. CHINA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 96. CHINA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 97. CHINA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. INDIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. INDIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 100. INDIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 101. INDIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. INDIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 103. INDIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 104. INDIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 114. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 115. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 117. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 118. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 156. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 157. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 159. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 160. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 176. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 178. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 181. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 182. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 186. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 188. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 189. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 199. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 202. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 203. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 206. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 207. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 209. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 210. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. ITALY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. ITALY CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 220. ITALY CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 221. ITALY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. ITALY CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 223. ITALY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 224. ITALY CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 241. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. POLAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. POLAND CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 248. POLAND CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 249. POLAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. POLAND CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 251. POLAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 252. POLAND CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. QATAR CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. QATAR CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 255. QATAR CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 256. QATAR CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. QATAR CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 258. QATAR CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 259. QATAR CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 283. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 284. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 286. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 287. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 302. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 303. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 304. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 305. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 307. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 308. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 316. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 318. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 323. CELL SURFACE MARKERS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 324. CELL SURFACE MARKERS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cell Surface Markers market, which are profiled in this report, include:
  • Abbott Laboratories
  • Abcam PLC
  • Agilent Technologies, Inc.
  • arigo Biolaboratories Corp.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cell Signaling Technology Inc.
  • Creative Bioarray
  • Creative Diagnostics
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • GenScript Biotech Corporation
  • Grifols SA
  • Merck KGaA
  • Nihon Kohden Corporation
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Qima Ltd.
  • R&D Systems, Inc.
  • ScienCell Research Laboratories, Inc.
  • Siemens Healthineers AG
  • Stemcell Technologies Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 858.27 Million
Forecasted Market Value ( USD ) by 2030 $ 1460 Million
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Cell Surface Markers - Global Strategic Business Report - Product Image

Cell Surface Markers - Global Strategic Business Report

  • Report
  • 683 Pages
  • Global
From
Cell Surface Marker Detection Global Market Report 2024 - Product Image

Cell Surface Marker Detection Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Cell Surface Marker Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Cell Surface Marker Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From
Cell Surface Markers Identification Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Cell Surface Markers Identification Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 92 Pages
  • Global
From
2024 Global Forecast for Cell Surface Markers Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Cell Surface Markers Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From

About the Cell Surface Marker Market

Cell surface markers are a type of biomarker used to identify and characterize cells. They are proteins found on the surface of cells that can be used to distinguish between different types of cells, such as healthy and diseased cells. Cell surface markers can be used to diagnose diseases, monitor disease progression, and evaluate the effectiveness of treatments. They can also be used to study the development and function of cells in the body. Cell surface markers are used in a variety of research and clinical applications, including cancer diagnostics, immunology, stem cell research, and drug development. Companies in the cell surface marker market include Bio-Rad Laboratories, Merck KGaA, Thermo Fisher Scientific, Becton Dickinson, and Agilent Technologies. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.